Correction of spectra for subject diversity
First Claim
Patent Images
1. A method of performing a non-invasive measurement of a target analyte present in a patient'"'"'s blood or tissue, the method comprising the steps of:
- compiling a database of spectral measurements for a plurality of subjects, the spectral measurements being taken transdermally by utilizing light, orthogonalizing the spectral measurements to a known chromophore measured in each of the subjects, thereby producing a set of orthogonalized spectral measurements, and deriving spectral shapes corresponding to one or more variability factors based on said orthogonalized spectral measurements.
1 Assignment
0 Petitions
Accused Products
Abstract
A non-invasive spectral measurement for a target analyte present in a subject'"'"'s tissue or blood derives spectral shapes corresponding to one or more human variability factors, such as, skin color, from spectra collected from a diverse calibration group of subjects. Another set of spectra are normalized based on the derived spectral shapes to generate a set of corrected spectra. The corrected spectra are then utilized to generate and/or enhance a calibration model for detecting and/or measuring the target analyte from one or more transderamlly obtained spectra of a subject.
60 Citations
21 Claims
-
1. A method of performing a non-invasive measurement of a target analyte present in a patient'"'"'s blood or tissue, the method comprising the steps of:
-
compiling a database of spectral measurements for a plurality of subjects, the spectral measurements being taken transdermally by utilizing light, orthogonalizing the spectral measurements to a known chromophore measured in each of the subjects, thereby producing a set of orthogonalized spectral measurements, and deriving spectral shapes corresponding to one or more variability factors based on said orthogonalized spectral measurements. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16)
-
-
13. A method of performing a non-invasive measurement of a target analyte present in a subject'"'"'s blood or tissue, comprising:
-
compiling a database of transdermally collected spectral measurements for a plurality of subjects, deriving spectral shapes corresponding to one or more human contributing factors from said collected spectra, and normalizing the collected spectra based on the derived spectral shapes to generate a set of corrected spectra.
-
-
17. A method of performing a non-invasive measurement of a target analyte present in a subject'"'"'s blood or tissue, comprising:
-
compiling a database of transdermally obtained spectra for a plurality of subjects, deriving spectral shapes corresponding to one or more human contributing factors from said transdermally obtained spectra, normalizing the transdermally obtained spectra based on the derived spectral shapes to generate a set of corrected spectra, and utilizing the corrected spectra to augment a calibration model.
-
-
18. A spectrometer for in vivo analysis of a target analyte present in a subject'"'"'s blood or tissue, comprising
a light source and a light collector for, respectively, illuminating and collecting light from the subject'"'"'s tissue and/or blood to provide a transdermal tissue spectrum, and a processor operative on the spectrum to measure the target analyte, wherein said processor operates with a calibration model based on a set of spectra obtained from a group of subjects having variable analyte concentrations and normalized by one or more spectral shapes indicative of one or more human variability factors.
-
21. A spectrometer for in vivo analysis of a target analyte, said spectrometer including a light source and light collector for illuminating and collecting light from tissue, and a processor operative on the collected light, wherein said processor operates to correct collected spectra with a transformation determined from spectral measurements taken in a selected population group, wherein the selected population group is a group selected to model spectral contribution of a human contributing factor, thereby enhancing detection of the target analyte in the presence of said human contributing factor.
Specification